| Literature DB >> 30970552 |
Priyanka Sahariah1, Dorota Cibor2, Dorota Zielińska3,4, Martha Á Hjálmarsdóttir5, Dawid Stawski6, Már Másson7.
Abstract
N,N,N-trimethyl chitosan (Entities:
Keywords: N,N,N-trimethyl chitosan; acidic hydrolysis; antibacterial activity; average molecular weight; chitosan
Mesh:
Substances:
Year: 2019 PMID: 30970552 PMCID: PMC6480509 DOI: 10.3390/ijms20071743
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Scheme 1Synthesis of N,N,N-trimethyl chitosan using conditions: (a) MeI, NaOH, DMF-H2O, room temperature, 48 h (these conditions were repeated 3 times).
Figure 11H-NMR spectrum of the highly quaternized N,N,N-trimethyl chitosan (TMC) (A) which was then subjected to hydrolysis in aqueous HCl and the chitosan starting material (B).
Table showing the Mw for the chitosan and TMC products obtained after different stages of hydrolysis.
| Reaction Time (h) | Acid Hydrolysis of TMC | Acid Hydrolysis of Chitosan | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 M HCl (60 °C) | Conc HCl (30 °C) | 1 M HCl (60 °C) | Conc HCl (30 °C) | |||||
| Mw (kDa) | Dispersity | Mw (kDa) | Dispersity | Mw (kDa) | Dispersity | Mw (kDa) | Dispersity | |
| 0.25 | 144 | 2.05 | 98 | 1.93 | 128 | 1.44 | 78 | 1.75 |
| 0.5 | 126 | 2.22 | 72 | 1.83 | 116 | 1.43 | 65 | 1.65 |
| 1 | 112 | 2.06 | 48 | 1.40 | 106 | 1.32 | 57 | 1.61 |
| 2 | 104 | 2.24 | 37 | 1.49 | 96 | 1.35 | 50 | 1.55 |
| 4 | 103 | 2.26 | 26 | 1.34 | 82 | 1.62 | 48 | 1.55 |
| 8 | 95 | 2.51 | 21 | 1.38 | 79 | 1.28 | 34 | 1.40 |
| 24 | 89 | 1.94 | 10 | 2.01 | 61 | 1.47 | 27 | 1.39 |
| 48 | 85 | 2.51 | 8 | 1.44 | 56 | 1.51 | 24 | 1.23 |
| 72 | 79 | 2.26 | 6 | 1.43 | 54 | 1.42 | 18 | 1.17 |
| 120 | 66 | 1.92 | 3 | 1.30 | 50 | 1.35 | 18 | 1.13 |
| 216 | 60 | 1.90 | 3 | 1.44 | 35 | 1.40 | 14 | 1.07 |
| 384 | – | – | 2 | 1.07 | – | – | 10 | 1.05 |
| 528 | – | – | 2 | 1.05 | – | – | 4 | 1.05 |
| 884 | – | – | – | – | – | – | 3 | 1.02 |
| 1388 | – | – | – | – | – | – | 2 | 1.03 |
‘–‘ denotes not done.
Figure 2Figure showing the Mw reduction with time for TMC (A) and chitosan (B) using concentrated (12 M) HCl (30 °C) and 1 M HCl (60 °C). The % reduction was calculated using the equation, % reduction = Mwp × 100/Mwi; where Mwp = Mw obtained at different time points and Mwi = initial Mw for chitosan and TMC.
Figure 3Figure showing the anomeric protons of TMC (A) and chitosan (B) in the 1H-NMR spectrum obtained after different stages of hydrolysis (1 h, 4 h, and 48 h) using 12 M HCl. COSY-NMR spectra for TMC oligomer (C) and chitosan oligomer (D) obtained after 48 h of hydrolysis.
Figure 4Figure showing the FTIR spectra of TMC (A) and chitosan (B) obtained after different stages of hydrolysis (1 h, 4 h, 48 h, and 528 h).
Table showing the MIC value for the different Mw for TMC and chitosan.
| TMC | CHITOSAN | ||
|---|---|---|---|
| Mw (kDa) | MIC (g/mL) | Mw (kDa) | MIC (g/mL) |
| 186 | 32 × 10−6 | 225 | 4.1 × 10−3 |
| 144 | 32 × 10−6 | 128 | 4.1 × 10−3 |
| 136 | 32 × 10−6 | 96 | 4.1 × 10−3 |
| 114 | 64 × 10−6 | 82 | 4.1 × 10−3 |
| 104 | 32 × 10−6 | 79 | 4.1 × 10−3 |
| 103 | 32 × 10−6 | 71 | 4.1 × 10−3 |
| 98 | 32 × 10−6 | 65 | 4.1 × 10−3 |
| 88 | 32 × 10−6 | 57 | 4.1 × 10−3 |
| 69 | 16 × 10−6 | 54 | 4.1 × 10−3 |
| 66 | 32 × 10−6 | 50 | 4.1 × 10−3 |
| 60 | 64 × 10−6 | 35 | 8.2 × 10−3 |
| 48 | 32 × 10−6 | 27 | 8.2 × 10−3 |
| 37 | 32 × 10−6 | 18 | 8.2 × 10−3 |
| 26 | 64 × 10−6 | 14 | 8.2 × 10−3 |
| 21 | 32 × 10−6 | 10 | 8.2 × 10−3 |
| 10 | 128 × 10−6 | 4 | ≥32.8 × 10−3 |
| 8 | 256 × 10−6 | 3 | ≥32.8× 10−3 |
| 6 | 512 × 10−6 | 2 | ≥32.8 × 10−3 |
| 4 | 4096 × 10−6 | 0.19 (glucosamine) | ≥32.768 × 10−3 |
| 3 | ≥32,768 × 10−6 | ||
| Gentamicin (positive control) | 0.5 × 10−6 | 1 × 10−6 | |
Figure 5Figure showing the variation of the antibacterial activity of TMC (A) and chitosan (B) with Mw; CMW = critical mole weight for high activity; DP = Degree of Polymerisation. In the Figure, MIC values were converted from mg/mL to g/mL for clarity. Since similar MIC values were obtained in replicate measurements, no experimental error is reported.